Mette Ilander

1.2k total citations
25 papers, 444 citations indexed

About

Mette Ilander is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Mette Ilander has authored 25 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 9 papers in Hematology. Recurrent topics in Mette Ilander's work include Immune Cell Function and Interaction (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and CAR-T cell therapy research (8 papers). Mette Ilander is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and CAR-T cell therapy research (8 papers). Mette Ilander collaborates with scholars based in Finland, Sweden and Norway. Mette Ilander's co-authors include Satu Mustjoki, Anna Kreutzman, Kimmo Porkka, Can Hekim, Jukka Vakkila, Oscar Brück, Olli Dufva, Annamari Ranki, Katariina Hannula‐Jouppi and Panu E. Kovanen and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Mette Ilander

25 papers receiving 441 citations

Peers

Mette Ilander

IMMUN

ONCOL

HEMAT

GENET

Noemi F. Pereira Brazil

Martín Bonamino Brazil

Olivia Simma Austria

Elisangela Santos-Valente Austria

Noriko Mitsuiki Japan

Paul Guglielmi France

Sebastian Fernandez‐Pol United States

Bushra Haq United States

Laura Tassone Italy

Randy Hurley United States

Noemi F. Pereira Brazil

Mette Ilander

243 ×1.0

IMMUN

91 ×0.6

ONCOL

264 ×1.9

HEMAT

122 ×1.0

81 ×1.0

GENET

Citations per year, relative to Mette Ilander Mette Ilander (= 1×) peers Noemi F. Pereira

Countries citing papers authored by Mette Ilander

Since Specialization

Citations

This map shows the geographic impact of Mette Ilander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Ilander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Ilander more than expected).

Fields of papers citing papers by Mette Ilander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Ilander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Ilander. The network helps show where Mette Ilander may publish in the future.

Co-authorship network of co-authors of Mette Ilander

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Ilander. A scholar is included among the top collaborators of Mette Ilander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Ilander. Mette Ilander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huuhtanen, Jani, Katriina Peltola, Tapio Lönnberg, et al.. (2023). Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma. Journal of Clinical Investigation. 133(6). 60 indexed citations

Huuhtanen, Jani, Shady Adnan Awad, Olli Dufva, et al.. (2023). Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation. Leukemia. 38(1). 109–125. 17 indexed citations

Ilander, Mette, Satu Mustjoki, Johan Richter, et al.. (2023). Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects. Annals of Hematology. 102(6). 1395–1408. 5 indexed citations

Guenther, Carla, Manlio Fusciello, Heidi Harjunpää, et al.. (2021). β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor Rejection. Cancer Immunology Research. 9(11). 1354–1369. 15 indexed citations

Huuhtanen, Jani, Oscar Brück, Karita Peltonen, et al.. (2021). Single-Cell Characterization of the Immune and Leukemic Cells Following Anti-TIM3 and Hypomethylating Agent Combination Therapy in Patients with AML or MDS. Blood. 138(Supplement 1). 801–801. 1 indexed citations

Hernberg, Micaela, Siru Mäkelä, Oscar Brück, et al.. (2020). Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients. Cancer Immunology Immunotherapy. 69(5). 717–730. 16 indexed citations

Söderlund, Stina, Inger Persson, Mette Ilander, et al.. (2020). Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy. Leukemia Research. 90. 106310–106310. 5 indexed citations

Lee, Moon Hee, Petrus Järvinen, Harry Nísen, et al.. (2019). Abstract A085: High infiltration of NK cells expressing elevated LAG-3 in a subgroup of renal cell carcinoma patients. Cancer Immunology Research. 7(2_Supplement). A085–A085. 1 indexed citations

Keskitalo, Salla, Emma Haapaniemi, Elísabet Einarsdóttir, et al.. (2019). Novel TMEM173 Mutation and the Role of Disease Modifying Alleles. Frontiers in Immunology. 10. 2770–2770. 43 indexed citations

10.

Hernberg, Micaela, Siru Mäkelä, Bhagwan Yadav, et al.. (2019). Abstract A130: Metastatic melanoma patients responding to PD1 therapy have higher proportion of peripheral blood NKT-cells. Cancer Immunology Research. 7(2_Supplement). A130–A130. 3 indexed citations

11.

Dufva, Olli, Khalid Saeed, Sara Gandolfi, et al.. (2019). CRISPR Screens Identify Mechanisms of Natural Killer Cell Evasion across Blood Cancers. Blood. 134(Supplement_1). 3597–3597. 3 indexed citations

12.

Ilander, Mette, Antti Mäkitie, Anna Kreutzman, et al.. (2018). Immune cell phenotype and functional defects in Netherton syndrome. Orphanet Journal of Rare Diseases. 13(1). 213–213. 21 indexed citations

13.

Lissina, Anna, James E. McLaren, Mette Ilander, et al.. (2018). Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vβ+ expansions. Scientific Reports. 8(1). 2534–2534. 2 indexed citations

14.

Kreutzman, Anna, Ana Marcos‐Jiménez, Mette Ilander, et al.. (2017). Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner. Clinical Cancer Research. 23(21). 6697–6707. 33 indexed citations

15.

Hekim, Can, Mette Ilander, Jun Yan, et al.. (2017). Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models. Cancer Immunology Research. 5(2). 157–169. 37 indexed citations

16.

Ilander, Mette, Anna Kreutzman, & Satu Mustjoki. (2014). IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia. OncoImmunology. 3(5). e28781–e28781. 5 indexed citations

17.

Ilander, Mette, Anna Kreutzman, Peter Rohoň, et al.. (2014). Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy. PLoS ONE. 9(1). e87794–e87794. 27 indexed citations

18.

Ilander, Mette, Can Hekim, & Satu Mustjoki. (2014). Immunology and Immunotherapy of Chronic Myeloid Leukemia. Current Hematologic Malignancy Reports. 9(1). 17–23. 25 indexed citations

19.

Kreutzman, Anna, Mette Ilander, Kimmo Porkka, Jukka Vakkila, & Satu Mustjoki. (2014). Dasatinib promotes Th1-type responses in granzyme B expressing T-cells. OncoImmunology. 3(5). e28925–e28925. 35 indexed citations

20.

Kinnunen, Paula M., Mette Ilander, Esa Koskela, et al.. (2011). Intracerebral Borna Disease Virus Infection of Bank Voles Leading to Peripheral Spread and Reverse Transcription of Viral RNA. PLoS ONE. 6(8). e23622–e23622. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact